Abstract
Evidence supporting the use of drug-eluting stents (DES) in saphenous vein graft (SVG) disease is uncertain. Previous studies have suggested that DES might reduce the re-intervention rate in SVG disease, with conflicting data on mortality. Thus, a meta-analysis was performed to compare outcomes of DES vs. bare metal stent (BMS) in SVG disease.
Lingua originale | English |
---|---|
pagine (da-a) | 280-289 |
Numero di pagine | 10 |
Rivista | Circulation Journal |
Volume | 75 |
Stato di pubblicazione | Pubblicato - 2011 |
Keywords
- Aged
- Aged, 80 and over
- Angioplasty
- Bias (Epidemiology)
- Clinical Trials as Topic
- Coronary Artery Bypass
- Coronary Disease
- Coronary Restenosis
- Diabetic Angiopathies
- Drug-Eluting Stents
- Female
- Follow-Up Studies
- Graft Occlusion, Vascular
- Humans
- Male
- Middle Aged
- Myocardial Infarction
- Odds Ratio
- Paclitaxel
- Postoperative Complications
- Randomized Controlled Trials as Topic
- Regression Analysis
- Saphenous Vein
- Sirolimus
- Stents
- Treatment Outcome